[Federal Register Volume 82, Number 249 (Friday, December 29, 2017)]
[Notices]
[Page 61795]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-28176]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Importer of Controlled Substances Application: ABBVIE LTD; 
Correction

ACTION: Notice; correction.

-----------------------------------------------------------------------

SUMMARY: The Drug Enforcement Administration (DEA) published a document 
in the Federal Register of December 1, 2017, concerning a notice of 
application that inadvertently misstated what the firm plans to do with 
imported tapentadol.

Correction

    In the Federal Register of December 1, 2017, in FR Doc. 2017-25921 
(82 FR 230), on page 230, in the second column, the last paragraph, 
correct the first sentence to read: The company plans to import bulk 
tapentadol (9780) to manufacture dosage form tapentadol (9780) for 
distribution to its customers.

Demetra Ashley,
Acting Assistant Administrator.
[FR Doc. 2017-28176 Filed 12-28-17; 8:45 am]
 BILLING CODE 4410-09-P